Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa

British Journal of Dermatology

Volumn 174, Issue 3, 2016, Pages 514-521

  Lima, A L ^a   Karl, I ^a,b   Giner, T ^a   Poppe, H ^a   Schmidt, M ^a   Presser, D ^a   Goebeler, M ^a   Bauer, Boris ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN A; CALGRANULIN B; CRYOPYRIN; INTERLEUKIN 17; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN S 100;

ADULT; ANTIBODY LABELING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; EXCISION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOPHENOTYPING; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; KERATINOCYTE; LANGERHANS CELL; MALE; MOLECULAR PATHOLOGY; NATURAL KILLER CELL; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INFILTRATE; SUPPURATIVE HIDRADENITIS; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; EPIDERMIS; HIDRADENITIS SUPPURATIVA; LYMPHOCYTE SUBPOPULATION; METABOLISM; PATHOLOGY; PHENOTYPE;

ADULT; EPIDERMIS; FEMALE; HIDRADENITIS SUPPURATIVA; HUMANS; INTERLEUKIN-17; KERATINOCYTES; LYMPHOCYTE SUBSETS; MALE; NEUTROPHILS; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; PHENOTYPE; S100 PROTEINS;

EID: 84949977353     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.14214     Document Type: Article

References (26)

1. Revuz J,. Hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2009; 23: 985-98.
2. Nazary M, van der Zee HH, Prens EP, et al,. Pathogenesis and pharmacotherapy of hidradenitis suppurativa. Eur J Pharmacol 2011; 672: 1-8.
3. Jemec GB,. Clinical practice. Hidradenitis suppurativa. N Engl J Med 2012; 366: 158-64.
4. von Laffert M, Stadie V, Wohlrab J, Marsch WC,. Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae. Br J Dermatol 2011; 164: 367-71.
5. van der Zee HH, de Ruiter L, Boer J, et al,. Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions. Br J Dermatol 2012; 166: 98-106.
6. von Laffert M, Helmbold P, Wohlrab J, et al,. Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis. Exp Dermatol 2010; 19: 533-7.
7. Schlapbach C, Hanni T, Yawalkar N, Hunger RE,. Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol 2011; 65: 790-8.
8. van der Zee HH, de Ruiter L, van den Broecke DG, et al,. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. Br J Dermatol 2011; 164: 1292-8.
9. Lynde CW, Poulin Y, Vender R, et al,. Interleukin 17A: toward a new understanding of psoriasis pathogenesis. J Am Acad Dermatol 2014; 71: 141-50.
10. Feldmeyer L, Werner S, French LE, Beer HD,. Interleukin-1, inflammasomes and the skin. Eur J Cell Biol 2010; 89: 638-44.
11. Cho KA, Suh JW, Lee KH, et al,. IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1 pathway. Int Immunol 2012; 24: 147-58.
12. Ehrchen JM, Sunderkötter C, Foell D, et al,. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 2009; 86: 557-66.
13. Simard JC, Cesaro A, Chapeton-Montes J, et al,. S100A8 and S100A9 induce cytokine expression and regulate the NLRP3 inflammasome via ROS-dependent activation of NF-κB. PLoS ONE 2013; 8: e72138.
14. Benoit S, Toksoy A, Ahlmann M, et al,. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis. Br J Dermatol 2006; 155: 62-6.
15. Wieland CW, Vogl T, Ordelman A, et al,. Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity? Br J Dermatol 2013; 168: 1252-8.
16. Bradford MM,. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
17. Penna A, Cahalan M,. Western Blotting using the Invitrogen NuPage Novex Bis Tris minigels. J Vis Exp 2007; 7: 264.
18. Shlyankevich J, Chen AJ, Kim GE, Kimball AB,. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. J Am Acad Dermatol 2014; 71: 1144-50.
19. Feldmeyer L, Keller M, Niklaus G, et al,. The inflammasome mediates UVB-induced activation and secretion of interleukin-1β by keratinocytes. Curr Biol 2007; 17: 1140-5.
20. Marzano AV, Ceccherini I, Gattorno M, et al,. Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases. Medicine (Baltimore) 2014; 93: e187.
21. Marzano AV, Cugno M, Trevisan V, et al,. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol 2010; 162: 100-7.
22. Marzano AV, Fanoni D, Antiga E, et al,. Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome. Clin Exp Immunol 2014; 178: 48-56.
23. Wallach D, Vignon-Pennamen MD,. From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research. J Am Acad Dermatol 2006; 55: 1066-71.
24. Marzano AV, Menicanti C, Crosti C, Trevisan V,. Neutrophilic dermatoses and inflammatory bowel diseases. G Ital Dermatol Venereol 2013; 148: 185-96.
25. Marzano AV, Ishak RS, Saibeni S, et al,. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol 2013; 45: 202-10.
26. Le Jan S, Plee J, Vallerand D, et al,. Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid. J Invest Dermatol 2014; 134: 2908-17.